[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

EMEA (Europe, Middle East and Africa) Axitinib Market Report 2017

December 2017 | 109 pages | ID: E9DAB26B99EEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Axitinib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Axitinib for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Axitinib market competition by top manufacturers/players, with Axitinib sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Pfizer
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Injection
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Renal Cancer Treatment
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Axitinib Market Report 2017

1 AXITINIB OVERVIEW

1.1 Product Overview and Scope of Axitinib
1.2 Classification of Axitinib
  1.2.1 EMEA Axitinib Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Axitinib Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Injection
  1.2.4 Others
1.3 EMEA Axitinib Market by Application/End Users
  1.3.1 EMEA Axitinib Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Renal Cancer Treatment
  1.3.3 Others
1.4 EMEA Axitinib Market by Region
  1.4.1 EMEA Axitinib Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Axitinib (2012-2022)
  1.5.1 EMEA Axitinib Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Axitinib Revenue and Growth Rate (2012-2022)

2 EMEA AXITINIB COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Axitinib Market Competition by Players/Manufacturers
  2.1.1 EMEA Axitinib Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Axitinib Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Axitinib Sale Price by Players (2012-2017)
2.2 EMEA Axitinib (Volume and Value) by Type/Product Category
  2.2.1 EMEA Axitinib Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Axitinib Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Axitinib Sale Price by Type (2012-2017)
2.3 EMEA Axitinib (Volume) by Application
2.4 EMEA Axitinib (Volume and Value) by Region
  2.4.1 EMEA Axitinib Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Axitinib Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Axitinib Sales Price by Region (2012-2017)

3 EUROPE AXITINIB (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Axitinib Sales and Value (2012-2017)
  3.1.1 Europe Axitinib Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Axitinib Revenue and Growth Rate (2012-2017)
3.2 Europe Axitinib Sales and Market Share by Type
3.3 Europe Axitinib Sales and Market Share by Application
3.4 Europe Axitinib Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Axitinib Sales Volume by Countries (2012-2017)
  3.4.2 Europe Axitinib Revenue by Countries (2012-2017)
  3.4.3 Germany Axitinib Sales and Growth Rate (2012-2017)
  3.4.4 France Axitinib Sales and Growth Rate (2012-2017)
  3.4.5 UK Axitinib Sales and Growth Rate (2012-2017)
  3.4.6 Russia Axitinib Sales and Growth Rate (2012-2017)
  3.4.7 Italy Axitinib Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Axitinib Sales and Growth Rate (2012-2017)

4 MIDDLE EAST AXITINIB (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Axitinib Sales and Value (2012-2017)
  4.1.1 Middle East Axitinib Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Axitinib Revenue and Growth Rate (2012-2017)
4.2 Middle East Axitinib Sales and Market Share by Type
4.3 Middle East Axitinib Sales and Market Share by Application
4.4 Middle East Axitinib Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Axitinib Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Axitinib Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Axitinib Sales and Growth Rate (2012-2017)
  4.4.4 Israel Axitinib Sales and Growth Rate (2012-2017)
  4.4.5 UAE Axitinib Sales and Growth Rate (2012-2017)
  4.4.6 Iran Axitinib Sales and Growth Rate (2012-2017)

5 AFRICA AXITINIB (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Axitinib Sales and Value (2012-2017)
  5.1.1 Africa Axitinib Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Axitinib Revenue and Growth Rate (2012-2017)
5.2 Africa Axitinib Sales and Market Share by Type
5.3 Africa Axitinib Sales and Market Share by Application
5.4 Africa Axitinib Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Axitinib Sales Volume by Countries (2012-2017)
  5.4.2 Africa Axitinib Revenue by Countries (2012-2017)
  5.4.3 South Africa Axitinib Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Axitinib Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Axitinib Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Axitinib Sales and Growth Rate (2012-2017)

6 EMEA AXITINIB MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Axitinib Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Axitinib Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview

7 AXITINIB MANUFACTURING COST ANALYSIS

7.1 Axitinib Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Axitinib

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Axitinib Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Axitinib Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA AXITINIB MARKET FORECAST (2017-2022)

11.1 EMEA Axitinib Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Axitinib Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Axitinib Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Axitinib Price and Trend Forecast (2017-2022)
11.2 EMEA Axitinib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Axitinib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Axitinib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Axitinib Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Axitinib Sales Forecast by Type (2017-2022)
11.7 EMEA Axitinib Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Axitinib
Figure EMEA Axitinib Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Axitinib Sales Volume Market Share by Type (Product Category) in 2016
Figure Injection Product Picture
Figure Others Product Picture
Figure EMEA Axitinib Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Axitinib by Application in 2016
Figure Renal Cancer Treatment Examples
Table Key Downstream Customer in Renal Cancer Treatment
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Axitinib Market Size (Million USD) by Region (2012-2022)
Figure Europe Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Axitinib Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Axitinib Revenue (Million USD) Status and Forecast by Countries
Figure Africa Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Axitinib Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Axitinib Sales Volume and Growth Rate (2012-2022)
Figure EMEA Axitinib Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Axitinib Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Axitinib Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Axitinib Sales Share by Players (2012-2017)
Figure 2016 Axitinib Sales Share by Players
Figure 2017 Axitinib Sales Share by Players
Figure EMEA Axitinib Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Axitinib Revenue (Million USD) by Players (2012-2017)
Table EMEA Axitinib Revenue Share by Players (2012-2017)
Table 2016 EMEA Axitinib Revenue Share by Players
Table 2017 EMEA Axitinib Revenue Share by Players
Table EMEA Axitinib Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Axitinib Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Axitinib Sales Share by Type (2012-2017)
Figure Sales Market Share of Axitinib by Type (2012-2017)
Figure EMEA Axitinib Sales Market Share by Type (2012-2017)
Table EMEA Axitinib Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Axitinib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Axitinib by Type in 2016
Table EMEA Axitinib Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Axitinib Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Axitinib Sales Share by Application (2012-2017)
Figure Sales Market Share of Axitinib by Application (2012-2017)
Figure EMEA Axitinib Sales Market Share by Application in 2016
Table EMEA Axitinib Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Axitinib Sales Share by Region (2012-2017)
Figure Sales Market Share of Axitinib by Region (2012-2017)
Figure EMEA Axitinib Sales Market Share in 2016
Table EMEA Axitinib Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Axitinib Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Axitinib by Region (2012-2017)
Figure EMEA Axitinib Revenue Market Share Regions in 2016
Table EMEA Axitinib Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Axitinib Revenue and Growth Rate (2012-2017)
Table Europe Axitinib Sales (K MT) by Type (2012-2017)
Table Europe Axitinib Market Share by Type (2012-2017)
Figure Europe Axitinib Market Share by Type in 2016
Table Europe Axitinib Sales (K MT) by Application (2012-2017)
Table Europe Axitinib Market Share by Application (2012-2017)
Figure Europe Axitinib Market Share by Application in 2016
Table Europe Axitinib Sales (K MT) by Countries (2012-2017)
Table Europe Axitinib Sales Market Share by Countries (2012-2017)
Figure Europe Axitinib Sales Market Share by Countries (2012-2017)
Figure Europe Axitinib Sales Market Share by Countries in 2016
Table Europe Axitinib Revenue (Million USD) by Countries (2012-2017)
Table Europe Axitinib Revenue Market Share by Countries (2012-2017)
Figure Europe Axitinib Revenue Market Share by Countries (2012-2017)
Figure Europe Axitinib Revenue Market Share by Countries in 2016
Figure Germany Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure France Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure UK Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Axitinib Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Axitinib Sales (K MT) by Type (2012-2017)
Table Middle East Axitinib Market Share by Type (2012-2017)
Figure Middle East Axitinib Market Share by Type (2012-2017)
Table Middle East Axitinib Sales (K MT) by Applications (2012-2017)
Table Middle East Axitinib Market Share by Applications (2012-2017)
Figure Middle East Axitinib Sales Market Share by Application in 2016
Table Middle East Axitinib Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Axitinib Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Axitinib Sales Volume Market Share by Countries in 2016
Table Middle East Axitinib Revenue (Million USD) by Countries (2012-2017)
Table Middle East Axitinib Revenue Market Share by Countries (2012-2017)
Figure Middle East Axitinib Revenue Market Share by Countries (2012-2017)
Figure Middle East Axitinib Revenue Market Share by Countries in 2016
Figure Saudi Arabia Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Axitinib Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Axitinib Sales (K MT) by Type (2012-2017)
Table Africa Axitinib Sales Market Share by Type (2012-2017)
Figure Africa Axitinib Sales Market Share by Type (2012-2017)
Figure Africa Axitinib Sales Market Share by Type in 2016
Table Africa Axitinib Sales (K MT) by Application (2012-2017)
Table Africa Axitinib Sales Market Share by Application (2012-2017)
Figure Africa Axitinib Sales Market Share by Application (2012-2017)
Table Africa Axitinib Sales Volume (K MT) by Countries (2012-2017)
Table Africa Axitinib Sales Market Share by Countries (2012-2017)
Figure Africa Axitinib Sales Market Share by Countries (2012-2017)
Figure Africa Axitinib Sales Market Share by Countries in 2016
Table Africa Axitinib Revenue (Million USD) by Countries (2012-2017)
Table Africa Axitinib Revenue Market Share by Countries (2012-2017)
Figure Africa Axitinib Revenue Market Share by Countries (2012-2017)
Figure Africa Axitinib Revenue Market Share by Countries in 2016
Figure South Africa Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Axitinib Sales (K MT) and Growth Rate (2012-2017)
Table Pfizer Axitinib Basic Information List
Table Pfizer Axitinib Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Axitinib Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Axitinib Sales Market Share in EMEA (2012-2017)
Figure Pfizer Axitinib Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Axitinib
Figure Manufacturing Process Analysis of Axitinib
Figure Axitinib Industrial Chain Analysis
Table Raw Materials Sources of Axitinib Major Manufacturers in 2016
Table Major Buyers of Axitinib
Table Distributors/Traders List
Figure EMEA Axitinib Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Axitinib Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Axitinib Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Axitinib Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Axitinib Sales Market Share Forecast by Region (2017-2022)
Table EMEA Axitinib Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Axitinib Revenue Market Share Forecast by Region (2017-2022)
Table Europe Axitinib Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Axitinib Sales Market Share Forecast by Countries (2017-2022)
Table Europe Axitinib Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Axitinib Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Axitinib Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Axitinib Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Axitinib Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Axitinib Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Axitinib Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Axitinib Sales Market Share Forecast by Countries (2017-2022)
Table Africa Axitinib Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Axitinib Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Axitinib Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Axitinib Sales Market Share Forecast by Type (2017-2022)
Table EMEA Axitinib Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Axitinib Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications